Related Experiment Video
Updated: Jul 24, 2026

Gene-targeted Random Mutagenesis to Select Heterochromatin-destabilizing Proteasome Mutants in Fission Yeast
Published on: May 15, 2018
A "no-hybrids" screen for functional antagonizers of human p53 transactivator function: dominant negativity in
S Waddell1, J R Jenkins, T Proikas-Cezanne
1Center for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Abstract:
We have developed a functional "no-hybrids" screen in the fission yeast Schizosaccharomyces pombe based on the transcription transactivator activity of human p53. The screen can be used to identify antagonizers and modulators of p53 activity. Expression of functional full-length human p53 is conditionally lethal to the screen reporter strains. Co-expression of specific inhibitory proteins promotes cell survival and growth. We have validated the "no-hybrids" system by (a) successful modeling of human wild-type p53 interaction with SV40 large T antigen, Mdm2 and a panel of tumor-derived human p53 mutants, (b) demonstrating the screening system's efficiency through identification of a dominant negative fragment of p53 itself in a library screen context and (c) using Drosophila p53 to demonstrate that the system can detect evolutionarily distant p53 homologues based on their transactivator activity. The "no-hybrids" screen will be of utility in searches for p53 function-modulators of both cellular and viral origin.
Insights
Researchers created a novel yeast screen to find human p53 protein modulators. This "no-hybrids" system identifies compounds that affect p53 activity, crucial for cancer research.
Area of Science:
- Molecular Biology
- Yeast Genetics
- Cancer Biology
Background:
- The tumor suppressor protein p53 plays a critical role in preventing cancer.
- Developing methods to identify modulators of p53 activity is essential for therapeutic development.
Purpose of the Study:
- To establish a functional screening system in Schizosaccharomyces pombe to identify antagonizers and modulators of human p53 activity.
- To validate the utility of the developed screening system for various p53-related interactions and homologues.
Main Methods:
- Development of a "no-hybrids" screen in fission yeast based on the transactivator activity of human p53.
- Conditional lethality of functional full-length human p53 drives the screen; co-expression of inhibitors promotes survival.
- Validation using interactions with SV40 large T antigen, Mdm2, p53 mutants, and screening for dominant-negative p53 fragments.
Main Results:
- Successful establishment and validation of the "no-hybrids" screen in Schizosaccharomyces pombe.
- Demonstrated ability to model known p53 interactions and identify novel modulators.
- Confirmed the system's capacity to detect evolutionarily distant p53 homologues based on transactivator function.
Conclusions:
- The "no-hybrids" screen provides a powerful tool for discovering modulators of p53 function.
- This system is applicable for identifying cellular and viral factors impacting p53 activity.
- The screen holds significant potential for advancing cancer research and therapeutic strategies targeting p53.
Related Concept Videos
Negative Regulator Molecules
In-vitro Mutagenesis
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

